We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+7.09%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$10.3B
AUM Growth
+$190M
Cap. Flow
-$399M
Cap. Flow %
-3.87%
Top 10 Hldgs %
17.03%
Holding
846
New
36
Increased
296
Reduced
321
Closed
83

Top Buys

Rank Stock Value
1
COTY icon
Coty
COTY
+$41.2M
2
DOV icon
Dover
DOV
+$36.8M
3
FIS icon
Fidelity National Information Services
FIS
+$36M
4
BDC icon
Belden
BDC
+$27.9M
5
CMP icon
Compass Minerals
CMP
+$26M

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 16.05%
3 Industrials 13.28%
4 Financials 12.25%
5 Consumer Discretionary 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WING icon
301
Wingstop
WING
$3.62B
$5.76M 0.06%
36,521
-20,997
-37% -$3.03M
HUBG icon
302
HUB Group
HUBG
$2.84B
$5.74M 0.06%
173,930
-5,110
-3% -$174K
TPIC
303
DELISTED
TPI Composites
TPIC
$5.71M 0.06%
117,841
-13,122
-10% -$645K
MDT icon
304
Medtronic
MDT
$109B
$5.7M 0.06%
45,974
+302
+0.7% +$37.9K
RBA icon
305
RB Global
RBA
$20.4B
$5.57M 0.05%
93,988
+5,595
+6% +$344K
USB icon
306
US Bancorp
USB
$98.3B
$5.56M 0.05%
97,708
+902
+0.9% +$52.9K
BIIB icon
307
Biogen
BIIB
$30.3B
$5.55M 0.05%
16,020
-20
-0.1% -$6.06K
SRI icon
308
Stoneridge
SRI
$193M
$5.53M 0.05%
187,542
+48,666
+35% +$1.54M
CE icon
309
Celanese
CE
$4.77B
$5.51M 0.05%
36,333
+20,235
+126% +$3.21M
BAC icon
310
Bank of America
BAC
$436B
$5.5M 0.05%
133,440
+4,095
+3% +$168K
ULTA icon
311
Ulta Beauty
ULTA
$21.8B
$5.48M 0.05%
15,840
-42,595
-73% -$14M
IWR icon
312
iShares Russell Mid-Cap ETF
IWR
$55.9B
$5.48M 0.05%
69,126
+2,121
+3% +$165K
FATE icon
313
Fate Therapeutics
FATE
$282M
$5.4M 0.05%
62,213
+3,325
+6% +$268K
KTOS icon
314
Kratos Defense & Security Solutions
KTOS
$8.66B
$5.34M 0.05%
187,497
+11,227
+6% +$297K
ADI icon
315
Analog Devices
ADI
$179B
$5.33M 0.05%
30,978
-13,043
-30% -$2.09M
ADUS icon
316
Addus HomeCare
ADUS
$2.16B
$5.3M 0.05%
60,804
-9,709
-14% -$944K
BMY icon
317
Bristol-Myers Squibb
BMY
$133B
$5.3M 0.05%
79,339
+1,210
+2% +$78.9K
PLMR icon
318
Palomar
PLMR
$3.59B
$5.28M 0.05%
70,028
-4,084
-6% -$294K
IEX icon
319
IDEX
IEX
$17B
$5.28M 0.05%
24,015
+12,894
+116% +$2.85M
KMB icon
320
Kimberly-Clark
KMB
$36.6B
$5.24M 0.05%
39,156
-910
-2% -$121K
HOLX
321
DELISTED
Hologic
HOLX
$5.19M 0.05%
77,881
-55,219
-41% -$3.69M
POWI icon
322
Power Integrations
POWI
$3.41B
$5.16M 0.05%
62,866
+3,816
+6% +$308K
UBSI icon
323
United Bankshares
UBSI
$6.63B
$5.15M 0.05%
141,057
-3,863
-3% -$152K
AVNT icon
324
Avient
AVNT
$3.35B
$5.14M 0.05%
104,514
+6,049
+6% +$306K
CSTE icon
325
Caesarstone
CSTE
$71.6M
$5.13M 0.05%
347,200
+16,200
+5% +$245K

Similar funds

Segall Bryant & Hamill's Q2 2021 Portfolio in Review

As of Q2 2021, Segall Bryant & Hamill held 846 positions worth $10.3B, up 1.9% from $10.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Segall Bryant & Hamill withdrew a net $399M in Q2 2021, closing 83 positions and reducing 321 holdings. Its most notable exit was Booking.com, an estimated $51.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Segall Bryant & Hamill opened a new position in Belden worth $28.9M.

  • Segall Bryant & Hamill's largest Q2 2021 buy was Belden: 571,007 shares worth $28.9M.
  • Segall Bryant & Hamill added most to Coty in Q2 2021, an estimated $41.2M increase.
  • Segall Bryant & Hamill's biggest Q2 2021 reduction was CoStar Group, cutting an estimated $97.3M.
  • Segall Bryant & Hamill fully exited Booking.com in Q2 2021, selling an estimated $51.4M.
  • Segall Bryant & Hamill's ten largest holdings make up 17% of its $10.3B portfolio in Q2 2021.
  • Segall Bryant & Hamill opened 36 new positions and closed 83 in Q2 2021.
  • Segall Bryant & Hamill's portfolio value rose 1.9% quarter-over-quarter to $10.3B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2021, filed 12 Aug 2021.